Zedjack33
Regular
Def not the case.
BRN Discussion Ongoing
- Thread starter TechGirl
- Start date
Easytiger
Regular
Thank you FF for response and all understood.
misslou
Founding Member
This is definitely not the case as I know my holdings are not as substantial as many others and I was made aware of the invitation.
From my understanding the company contacted a few shareholders in a few states and asked them to organise it.
Last edited:
FYI: On the conference website, the session to which Pia Turcinov had been invited as a speaker, is missing the first and last panellist from your screenshot and also lists a different moderator. Unfortunately there was nothing else to find out, even when clicking that unmistakeable red Find Out More button.
Pia Turcinov AM - Indo-Pacific Space & Earth Conference
spaceandearthconference.com
View attachment 49630
Despite ending up in that cul-de-sac, I was still in dot-joining mood, so I had a closer look at Fund WA instead, where Pia Turcinov is a General Partner. They describe themselves as a “Seed To Series-A venture fund in Western Australia” and their mission statement is “to back the state’s innovative, high growth and scalable opportunities at the early commercialisation stages.”
View attachment 49632
View attachment 49635
So far, Fund WA has invested in two local start-ups (in August 2023 resp Sept 2023). The second one, medtech and biosensor company VitalTrace (www.vitaltrace.com.au), looks as if it was right up our alley, even though there is no specific mention of neuromorphic technology.
The people behind this innovative start-up based in Perth are hoping to commercialise their continuous scalp lactate monitoring DelivAssure biosensor, a real-time fetal distress monitoring device to detect hypoxia (lack of oxygen) in babies during labour, which they claim is superior to cardiotocography (CTG), the current gold standard of intrapartum (during childbirth) fetal monitoring. According to VitalTrace, DelivAssure will help clinicians to easily identify fetal distress during labour, allowing them to take early action to prevent complications such as brain damage, and at the same time reduce unnecessary C-sections.
Perth cardiologist A/Prof Dr Michael Nguyen, another General Partner of Fund WA, recently posted a short clip (worth watching) of VitalTrace being featured on Seven Network.
Michael Nguyen on LinkedIn: VitalTrace featured on Channel 7
Thank you Seven network for promoting such a great company and the efforts of its founders. Thanks FundWA for supporting this innovation ecosystem.www.linkedin.com
View attachment 49646
I subsequently searched for ‘VitalTrace’ here on TSE, which yielded one result: @Fact Finder had already come across this Perth start-up about 1.5 years ago.
View attachment 49668
Even if VitalTrace did not yet know about Akida back then, they would have found out about Brainchip’s disruptive tech by now through Pia Turcinov. Whether they are actually implementing it or not remains to be seen.
There is of course also the possibility that Fund WA invested in VitalTrace for the very reason the team behind the start-up plans on implementing Akida into their DelivAssure biosensor, on their mission “to create a new global standard of care for keeping mothers and babies safe during childbirth” and that Pia Turcinov and her investment partners are convinced that the resulting tech is going to be a winning combination, enabling the start-up founders’ vision for the novel biosensor to become an indispensable device for obstetricians and midwives around the globe, saving lives and helping to prevent birth complications due to hypoxia and avoiding unnecessary emergency C-sections. And all of this resulting in a massive decrease in healthcare costs, too.
While Brainchip is not (or not yet? another company behind an NDA?) listed as one of VitalTrace’s partners, I noticed both the University of Western Australia as well as the Perron Institute for Neurological and Translational Science in Perth are, and we have connections to both institutions through the three members on our Scientific Advisory Board: Prof Adam Osseiran, Professor Barry Marshall as well as Prof Alan Harvey. Of course there are also countless other potential (non BRN-related) connections between VitalTrace and the Perron Institute resp UWA. Unfortunately, I couldn’t spot any of our SAB member names on the university project pages I found (eg https://research-repository.uwa.edu...el-monitoring-device-to-detect-hypoxia-during and more links to collaborations with UTS and Monash over a three year period from 01/01/2022-31/12/2024), but they could still have put VitalTrace in touch with Brainchip or vice versa.
And even if Brainchip is not involved, I sincerely hope this innovative Perth start-up will be successful in commercialising their invention.
FundWA announces 2nd investment, in VitalTrace
By
Pankaj Sharma
-
21 September 2023
0
422
https://www.facebook.com/sharer.php?u=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/
https://twitter.com/intent/tweet?text=FundWA+announces+2nd+investment,+in+VitalTrace&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&via=Startup+News
https://www.linkedin.com/shareArticle?mini=true&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&title=FundWA+announces+2nd+investment,+in+VitalTrace
FUND WA (Left to Right
Fund WA's Glenn Butcher, Pia Turcinov, Dr Michael Nguyen, Trent Rachow. Absent are Asheesh Malaney General Partner and Glenn Murray Venture Partner. Photo supplied.
WA-based venture fund Fund WA has announced its second investment from its first fund in backing Perth-based medtech and biosensor company VitalTrace.
The former WA Innovator of the Year winners (2021, Wesfamers Wellbeing Award) co-founders Dr Arjun Kaushik and Dr Michael Challenor are leading cutting-edge research and developing manufacturing capability, all focused on solving a serious problem that is worth $3b per annum.
A recent event hosted by VitalTrace to celebrate the investment was an opportunity for FundWA investors to meet some of the team and hear about the most recent milestones reached in commercialising their world-first DelivAssurebiosensor.
VitalTrace team. Image supplied.
Glenn Butcher, CEO and one of the four General Partners of Fund WA said he was happy to support an investment to create a new global standard of care for keeping mothers and babies safe during childbirth.
“This is a WA startup, based here, manufacturing from here and taking this ground-breaking technology to the world, from WA,” he said.
“Our investment in VitalTrace is a commitment to supporting transformative West Australian innovation that can enhance the lives of countless individuals. Our focus is on high growth potential and is not limited to any specific industry sectors. We firmly believe investable talent can come from anywhere.”
VitalTrace product suite – including the DelivAssure biosensor (on the table). Image supplied
Earlier this year FundWA received support through the WA State Government’s New Industries Fund, from the Department of Jobs, Tourism, Science and Innovation which has provided some operational funding for the first three years to assist in the establishment of the fund under the WA Ventures Support (WAVES) pilot program.
To date, FundWA has vetted over 160 startup companies in WA and is actively encouraging early conversations with founders looking to scale through venture capital funding.
~~
For further information visit www.fundwa.com.au
View attachment 49666
Good morning,
Despite what someone recently posted about Pia Turcinov being next to useless, questioning why she is even on our BOD and has she
actually brought anything to date to the Brainchip Holdings Ltd table, whilst receiving an NED's fee.
I found that a rather harsh view, having met Pia she came across to me as a very strong business minded lady, who I know Peter has a lot
of respect for, she has numerous contacts who can open up doors, becoming the first female to enter Brainchip's Board, having the founders
blessing I would have thought was enough.
Who got the WA Minister for Emergency Services; Innovation and the Digital Economy; Medical Research; Stephen Dawson to come to
visit our Perth Research Innovation Centre, I'm pretty sure it was Pia, but happy to be corrected by Tony if wrong.
It's all about teamwork, and Perth has a very solid team, I can't state as a fact, but I'd strongly suggest Pia has already opened up channels
that may have not at this stage been possible, mainly based around Peter's and the Perth teams already heavy workload.
Whatever the actual figure and/or bonus shares she receives, I personally believe it will pay off over the next 3 year period, if the Board
decides to part ways with Pia, I'm sure it will be mutual if it ever eventuates.
Have a great day ahead....Tech
At the risk of being boring....or worse dumb and boring.....I've now own 1.245m shares.
My current/ultimate wife (I am MUCH too old to consider her as penultimate) has this all set for my tombstone engraving....
GOOD GUY.....GULLIBLE THOUGH
(And to emphasize, she married me)
DYOD
My current/ultimate wife (I am MUCH too old to consider her as penultimate) has this all set for my tombstone engraving....
GOOD GUY.....GULLIBLE THOUGH
(And to emphasize, she married me)
DYOD
Last edited:
AI_Inquirer
Regular
To those who took part in the retail holder meeting with Sean and his team, was there any conversation regarding our existing customers Megachip or Renesas, and any feedback on the progress or roadblocks our existing customers have had?
FYI: On the conference website, the session to which Pia Turcinov had been invited as a speaker, is missing the first and last panellist from your screenshot and also lists a different moderator. Unfortunately there was nothing else to find out, even when clicking that unmistakeable red Find Out More button.
Pia Turcinov AM - Indo-Pacific Space & Earth Conference
View attachment 49630
Despite ending up in that cul-de-sac, I was still in dot-joining mood, so I had a closer look at Fund WA instead, where Pia Turcinov is a General Partner. They describe themselves as a “Seed To Series-A venture fund in Western Australia” and their mission statement is “to back the state’s innovative, high growth and scalable opportunities at the early commercialisation stages.”
View attachment 49632
View attachment 49635
So far, Fund WA has invested in two local start-ups (in August 2023 resp Sept 2023). The second one, medtech and biosensor company VitalTrace (www.vitaltrace.com.au), looks as if it was right up our alley, even though there is no specific mention of neuromorphic technology.
The people behind this innovative start-up based in Perth are hoping to commercialise their continuous scalp lactate monitoring DelivAssure biosensor, a real-time fetal distress monitoring device to detect hypoxia (lack of oxygen) in babies during labour, which they claim is superior to cardiotocography (CTG), the current gold standard of intrapartum (during childbirth) fetal monitoring. According to VitalTrace, DelivAssure will help clinicians to easily identify fetal distress during labour, allowing them to take early action to prevent complications such as brain damage, and at the same time reduce unnecessary C-sections.
Perth cardiologist A/Prof Dr Michael Nguyen, another General Partner of Fund WA, recently posted a short clip (worth watching) of VitalTrace being featured on Seven Network.
Michael Nguyen on LinkedIn: VitalTrace featured on Channel 7
Thank you Seven network for promoting such a great company and the efforts of its founders. Thanks FundWA for supporting this innovation ecosystem.
View attachment 49646
I subsequently searched for ‘VitalTrace’ here on TSE, which yielded one result: @Fact Finder had already come across this Perth start-up about 1.5 years ago.
View attachment 49668
Even if VitalTrace did not yet know about Akida back then, they would have found out about Brainchip’s disruptive tech by now through Pia Turcinov. Whether they are actually implementing it or not remains to be seen.
There is of course also the possibility that Fund WA invested in VitalTrace for the very reason the team behind the start-up plans on implementing Akida into their DelivAssure biosensor, on their mission “to create a new global standard of care for keeping mothers and babies safe during childbirth” and that Pia Turcinov and her investment partners are convinced that the resulting tech is going to be a winning combination, enabling the start-up founders’ vision for the novel biosensor to become an indispensable device for obstetricians and midwives around the globe, saving lives and helping to prevent birth complications due to hypoxia and avoiding unnecessary emergency C-sections. And all of this resulting in a massive decrease in healthcare costs, too.
While Brainchip is not (or not yet? another company behind an NDA?) listed as one of VitalTrace’s partners, I noticed both the University of Western Australia as well as the Perron Institute for Neurological and Translational Science in Perth are, and we have connections to both institutions through the three members on our Scientific Advisory Board: Prof Adam Osseiran, Professor Barry Marshall as well as Prof Alan Harvey. Of course there are also countless other potential (non BRN-related) connections between VitalTrace and the Perron Institute resp UWA. Unfortunately, I couldn’t spot any of our SAB member names on the university project pages I found (eg https://research-repository.uwa.edu...el-monitoring-device-to-detect-hypoxia-during and more links to collaborations with UTS and Monash over a three year period from 01/01/2022-31/12/2024), but they could still have put VitalTrace in touch with Brainchip or vice versa.
And even if Brainchip is not involved, I sincerely hope this innovative Perth start-up will be successful in commercialising their invention.
FundWA announces 2nd investment, in VitalTrace
By
Pankaj Sharma
-
21 September 2023
0
422
https://www.facebook.com/sharer.php?u=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/
https://twitter.com/intent/tweet?text=FundWA+announces+2nd+investment,+in+VitalTrace&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&via=Startup+News
https://www.linkedin.com/shareArticle?mini=true&url=https://startupnews.com.au/2023/09/21/fundwa-announces-2nd-investment-in-vitaltrace/&title=FundWA+announces+2nd+investment,+in+VitalTrace
WA-based venture fund Fund WA has announced its second investment from its first fund in backing Perth-based medtech and biosensor company VitalTrace.
The former WA Innovator of the Year winners (2021, Wesfamers Wellbeing Award) co-founders Dr Arjun Kaushik and Dr Michael Challenor are leading cutting-edge research and developing manufacturing capability, all focused on solving a serious problem that is worth $3b per annum.
A recent event hosted by VitalTrace to celebrate the investment was an opportunity for FundWA investors to meet some of the team and hear about the most recent milestones reached in commercialising their world-first DelivAssurebiosensor.
VitalTrace team. Image supplied.
Glenn Butcher, CEO and one of the four General Partners of Fund WA said he was happy to support an investment to create a new global standard of care for keeping mothers and babies safe during childbirth.
“This is a WA startup, based here, manufacturing from here and taking this ground-breaking technology to the world, from WA,” he said.
“Our investment in VitalTrace is a commitment to supporting transformative West Australian innovation that can enhance the lives of countless individuals. Our focus is on high growth potential and is not limited to any specific industry sectors. We firmly believe investable talent can come from anywhere.”
VitalTrace product suite – including the DelivAssure biosensor (on the table). Image supplied
Earlier this year FundWA received support through the WA State Government’s New Industries Fund, from the Department of Jobs, Tourism, Science and Innovation which has provided some operational funding for the first three years to assist in the establishment of the fund under the WA Ventures Support (WAVES) pilot program.
To date, FundWA has vetted over 160 startup companies in WA and is actively encouraging early conversations with founders looking to scale through venture capital funding.
~~
For further information visit www.fundwa.com.au
View attachment 49666
Thanks for the effort put into your response, much appreciate the level of detail. As you said seems like a good company to follow if a great cause. Keep a close eye and hopefully find BRN is involved.
When I see Neil from Rio Tinto next to Pia from BRN such a good fit for preventative maintenance across its rail networks, autonomous fleet, even real-time emissions monitoring for accurate fleet emissions record.
Thanks again.
jtardif999
Regular
‘We commercialised’ - the commercialisation process for a company in the business that BrainChip are in could take years to come to fruition. You make it sound like they commercialised so where’s the money, it’s not that straightforward. AIMO.
Unless Sean pu
Unless one of the biggest rabbit tricks are pulled out of his hat he is gone for all money and won’t be back next AGM,we had the numbers for strike 1 and now with more shareholders pissed with management and the directors all looking like strike 2 will be a forgone conclusion. As besides you select few who get access should,not get,at least 70 percent of shareholders are pissed,why question and speak to happy investors it’s the unhappy that will vote with their feet.
Dhm
Regular
This landed in my inbox, apologies if it has been posted before.
https://brainchip.com/tenns-a-new-approach-to-streaming-and-sequential-data/
And this is the video accompanying it
https://brainchip.com/tenns-a-new-approach-to-streaming-and-sequential-data/
And this is the video accompanying it
thelittleshort
Top Bloke
Bernd Westhoff on LinkedIn: RA8 Series CM85-based MCUs Running Cyberon NLU
Advanced natural language processing on the Renesas RA8M1 MCU using the Arm Cortex M85 core and Cyberon solution without the needs for a cloud connection…
Kachoo
Regular
I'm not so confident with this strike 2. I feel it looks like there is an attempt to shake the board possibly for a more accommodating board for a cheap take-over. Many of the adgendas hear and complaints have hidden positions and marketing plans people.
Let's be honest the price was over the top at 1.20s arguably people will build their own opinions on value. This is mine.
At this price we can argue we are undervalue the board feels that too.
So if you forget the past and look at the value being say discounted just my opinion of 66% or 3 times today's prices what would you do with your new money. This is not financial advice but yeah I would look at getting 3 dollars returned on one dollar and not keep crying about the past my opinion.
But if your a genuine holder your not doing your wallet a favour by continually bagging management .
Heck BRN has had many job opening why do you not apply and improve the outlook your add value they will give you shares too and pay you. Well likely not as your not qualified for the job hence your opinions likely result as shitty advice.
Now if your agenda is to keep sowing doubt we'll that is your agenda.
As genuine investor I'm more shocked at all the negative responses then the pumps that happened. But I guess freedom of speech is yours.
Just don't bite the hand that may feed you eventually you may regret it.
DYOD - Do Your Own Divorce!
Schnitzel lover
Regular
I don’t quite understand what there is to be gained by sharing this information on this forum FF? I am absolutely staggered you would put this down into words on a public forum..
Why would you basically spell out to the world that there’s a group of investors who get private privileges with the company to partake in meetings that are not made open to all shareholders?
For some, it brings into question the sudden price and volume movement of a week ago and makes questionable your motives of suddenly reappearing here. You would NOT want to have been buying on market under such circumstances.
However, fret not.
I can say with unquestionable fact. All the people that attended such meetings have no measurable advantage over other shareholders. It often works the other way because you feel connected and are more likely to fall for the A-type speak of ambitious executives, over the plain and simple facts that stare us in the face.. Not yet commercially successful!
What it highlights most of all his how unprofessional it makes management of the company come across and continued poor form in the way they conduct business with select shareholders..
As always, this is just my opinion..
For me, i am kind of okay with the first strike, the management needed to given a message of shareholder discontent. But beyond that, thinking of 2nd strike makes no sense. It will only negatively impact the company and the shareholders. So, people here continuously talking of second strikes could have an agenda, that certainly won’t be favor of the shareholders.
wilzy123
Founding Member
You sound confused champ.
First you imply that there are advantages: "that there’s a group of investors who get private privileges with the company to partake in meetings that are not made open to all shareholders?".
Then you say that there isn't an advantage: "All the people that attended such meetings have no measurable advantage over other shareholders"
Then you say that it is a disadvantage and imply that those who participate are most likely gullible fools "It often works the other way because you feel connected and are more likely to fall for the A-type speak of ambitious executives, over the plain and simple facts that stare us in the face"
Which is it lol? Or were you just talking to yourself on a public forum?
TheUnfairAdvantage
Regular
Once again Wilzy. No substance added. At least we didn’t get a gif.
He actually makes a good point. Definitely not confused at all.
I think the disclosure of the special invite meeting and the secrecy of it all smells a little. It’s a bit like Sean and Tony have made the special meetings with the movers and shakers of TSEx to help calm the pitch fork wielding tribe. Might have back fired due to the tribe feeling a little betrayed and left of centre right at this point.
I hold what I believe to be a considerable sum of shares and belong to a group of friends, family and associates who together hold a very large number of shares. Our collective sentiment is definitely “concerned” with the current state of commercialisation but not “worried”. The need to brief a small number of individuals on this commercialisation strategy adds to the “ concern”. Schnitty has a right to also express an opinion as do I. Your right of reply doesn’t necessarily mean you are “right”.
I’m guessing your reply also reflects your “concern” on the current state of play.
Now this is something that we can definitely without a doubt say is us!View attachment 49671
View attachment 49673
Bernd Westhoff on LinkedIn: RA8 Series CM85-based MCUs Running Cyberon NLU
Advanced natural language processing on the Renesas RA8M1 MCU using the Arm Cortex M85 core and Cyberon solution without the needs for a cloud connection…
Damo4
Regular
Sounds like people are focussing on the the wrong part of these meeting discussions.
Attending members have confirmed nothing was said that provided extra information.
Instead it was about an opportunity to listen to what some SH's concerns were.
It sounds like every time one of these meeting is held the concerns belong to the same group of thoughts.
Communication is a 2 way street. I see many posts about their complaints falling on deaf ears, yet when they are raised constructively directly with management, you aren't happy?
People are peppering Tony's emails with abuse then turn around and ask why they aren't getting responses?
Just a bit confused why people feel so entitled to face to face meetings with management, when they have likely never attended AGMs, contacted members via email and/or maintained a professional relationships with individual members.
You've got to remember this forum represents less than 10% of the total holders (closer to 5%).
Any "influence" you think FF, SERA2g, Chapman etc is a bit silly when thinking of the larger picture.
90% of holders aren't on this forum, so a TSEx conspiracy is wild.
Just sounds like people are feeling left out.
Attending members have confirmed nothing was said that provided extra information.
Instead it was about an opportunity to listen to what some SH's concerns were.
It sounds like every time one of these meeting is held the concerns belong to the same group of thoughts.
Communication is a 2 way street. I see many posts about their complaints falling on deaf ears, yet when they are raised constructively directly with management, you aren't happy?
People are peppering Tony's emails with abuse then turn around and ask why they aren't getting responses?
Just a bit confused why people feel so entitled to face to face meetings with management, when they have likely never attended AGMs, contacted members via email and/or maintained a professional relationships with individual members.
You've got to remember this forum represents less than 10% of the total holders (closer to 5%).
Any "influence" you think FF, SERA2g, Chapman etc is a bit silly when thinking of the larger picture.
90% of holders aren't on this forum, so a TSEx conspiracy is wild.
Just sounds like people are feeling left out.
Similar threads
